Skip to content

Padeliporfin

Tookad (padeliporfin) is a small molecule pharmaceutical. Padeliporfin was first approved as Tookad on 2017-11-10. It has been approved in Europe to treat prostatic neoplasms.
Trade Name Tookad
Common Name Padeliporfin
Indication prostatic neoplasms
Drug Class Benzoporphyrin derivatives
Padeliporfin
Get full access now